Apr 05, 2022

Colin Hill to Speak at the 33rd Annual Cancer Progress Conference

The 33rd Annual Cancer Progress Conference, is taking place on May 10th-12th this year. On Tuesday, May 10th, our CEO, Colin Hill, will take part in a panel discussion titled “How to Catch and Treat Cancer Early”.

Colin will be joined by Peter Bach, MD, CMO, Delfi Diagnostics; Kapil Dhingra, MB, BS, Managing Member, KAPital Consulting LLC; Christoph Lengauer, PhD, MBA, Partner, Third Rock Ventures; Thrive/Exact Sciences; and John Sninsky, UCSF Clinical & Translational Science Institute, Catalyst Advisor, Diagnostics, CSO, CareDx. The session will be moderated by Brian Leyland Jones, MB BS, PhD, CMO, National Foundation for Cancer Research.

This panel will update current progress on “the holy grail”: an annual affordable test to detect cancer at its earliest stages as part of an annual physical examination. The next obvious challenge will be administration of therapies to treat (and hopefully destroy) malignant subclones  before the cancer is detected by current conventional methods.

Panel session | 11:00 AM – 12:00 PM ET | How to Catch and Treat Cancer Early

More information: https://cancerprogress.live/wp-content/uploads/2022/04/33rd-Annual-Cancer-Progress-Conference-Agenda-March-28.pdf